These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28947471)

  • 1. SPR741, an Antibiotic Adjuvant, Potentiates the
    Zurawski DV; Reinhart AA; Alamneh YA; Pucci MJ; Si Y; Abu-Taleb R; Shearer JP; Demons ST; Tyner SD; Lister T
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947471
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia.
    Oliva A; Cipolla A; Vullo V; Venditti M; Mastroianni CM; Falcone M
    New Microbiol; 2017 Jul; 40(3):205-207. PubMed ID: 28675246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS
    Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
    Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
    J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options for Acinetobacter baumannii infections.
    Vila J; Pachón J
    Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments.
    Jacobs AC; Thompson MG; Black CC; Kessler JL; Clark LP; McQueary CN; Gancz HY; Corey BW; Moon JK; Si Y; Owen MT; Hallock JD; Kwak YI; Summers A; Li CZ; Rasko DA; Penwell WF; Honnold CL; Wise MC; Waterman PE; Lesho EP; Stewart RL; Actis LA; Palys TJ; Craft DW; Zurawski DV
    mBio; 2014 May; 5(3):e01076-14. PubMed ID: 24865555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
    Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
    Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases.
    Özvatan T; Akalın H; Sınırtaş M; Ocakoğlu G; Yılmaz E; Heper Y; Kelebek N; İşçimen R; Kahveci F
    Respirology; 2016 Feb; 21(2):363-9. PubMed ID: 26635315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR
    Pan S; Huang X; Wang Y; Li L; Zhao C; Yao Z; Cui W; Zhang G
    Antimicrob Resist Infect Control; 2018; 7():8. PubMed ID: 29387342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of a multidrug-resistant/pandrug-resistant nosocomial polymicrobial infection with Klebsiella pneumoniae, Providencia rettgeri, and Acinetobacter baumannii from Rural Maharashtra, India.
    Karad DD; Somani Y; Khande H; Yadav B; Kharat AS
    Acta Biochim Pol; 2020 Jul; 67(3):387-392. PubMed ID: 32735431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin].
    Motaouakkil S; Charra B; Hachimi A; Benslama A
    Ann Fr Anesth Reanim; 2006 May; 25(5):543-4. PubMed ID: 16488103
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae.
    Clock SA; Tabibi S; Alba L; Kubin CJ; Whittier S; Saiman L
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):343-6. PubMed ID: 23601454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
    Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
    J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of ventilator associated pneumonia with a new antibiotic adjuvant entity (ceftriaxone+sulbactam+disodium edetate) - A novel approach to spare carbapenems.
    Sathe P; Maddani S; Kulkarni S; Munshi N
    J Crit Care; 2017 Oct; 41():145-149. PubMed ID: 28535440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
    Konai MM; Haldar J
    ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Aydemir H; Akduman D; Piskin N; Comert F; Horuz E; Terzi A; Kokturk F; Ornek T; Celebi G
    Epidemiol Infect; 2013 Jun; 141(6):1214-22. PubMed ID: 22954403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections Due to Acinetobacter baumannii in the ICU: Treatment Options.
    Lynch JP; Zhanel GG; Clark NM
    Semin Respir Crit Care Med; 2017 Jun; 38(3):311-325. PubMed ID: 28578555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Pneumonia Successfully Treated with a Novel Antibiotic Combination.
    Zaidan N; Hornak JP; Reynoso D
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0092421. PubMed ID: 34370576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of antimicrobial resistance among Acinetobacter species: a global threat.
    Clark NM; Zhanel GG; Lynch JP
    Curr Opin Crit Care; 2016 Oct; 22(5):491-9. PubMed ID: 27552304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.